Home › All Companies › BNTC › Insider Trading

Benitec Biopharma Inc. (BNTC) — Insider Trading

AI-Powered SEC Filing Analysis

← All BNTC filings
Latest Insider Trading Filed: 2026-01-26

Key Insights

  • Insider Sharon Mates acquired 31,500 stock options in Benitec Biopharma, suggesting potential confidence in the company's future prospects.
  • The options will vest on the earlier of the company's next annual stockholders' meeting or December 1, 2026, indicating a near-term vesting timeline.
  • This insider transaction could signal Mates' belief in Benitec Biopharma's growth potential, as executives tend to hold on to shares they acquire.
Sentiment: Positive Significance: 7/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-01-26. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for Benitec Biopharma Inc.

Quarterly Report Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.